321550 Stock Chart & Stats
₩4150.00
-₩230.00(-5.25%)
―
--
Day’s Range― - ―
52-Week Range₩3,415.00 - ₩13,700.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)256.13K
Market Cap
₩124.66B
Enterprise Value₩129.93K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-143.29
Shares Outstanding30,038,475
10 Day Avg. Volume163,378
30 Day Avg. Volume256,127
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
321550 FAQ
What was TiumBio Co., Ltd.’s price range in the past 12 months?
TiumBio Co., Ltd. lowest stock price was ₩3415.00 and its highest was ₩13700.00 in the past 12 months.
What is TiumBio Co., Ltd.’s market cap?
TiumBio Co., Ltd.’s market cap is ₩124.66B.
When is TiumBio Co., Ltd.’s upcoming earnings report date?
TiumBio Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 86 days.
How were TiumBio Co., Ltd.’s earnings last quarter?
TiumBio Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -₩143.295 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is TiumBio Co., Ltd. overvalued?
According to Wall Street analysts TiumBio Co., Ltd.’s price is currently Undervalued.
Does TiumBio Co., Ltd. pay dividends?
TiumBio Co., Ltd. does not currently pay dividends.
What is TiumBio Co., Ltd.’s EPS estimate?
TiumBio Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TiumBio Co., Ltd. have?
TiumBio Co., Ltd. has 30,038,475 shares outstanding.
What happened to TiumBio Co., Ltd.’s price movement after its last earnings report?
TiumBio Co., Ltd. reported an EPS of -₩143.295 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.412%.
Which hedge fund is a major shareholder of TiumBio Co., Ltd.?
Currently, no hedge funds are holding shares in KR:321550
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Macrogen, Inc.
―
CMG Pharmaceutical Co., Ltd.
―
Genexine, Inc.
―
Aptabio Therapeutics, Inc.
―
Celemics, Inc.
―